Is age an independent risk factor for chemically induced acute myelogenous leukemia in children? (Q36905628)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

review article

1 reference

title

Is age an independent risk factor for chemically induced acute myelogenous leukemia in children? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

David W Pyatt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sean M Hays

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

Journal of Toxicology and Environmental Health Part B: Critical Reviews

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

379-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

Acute leukemia due to chronic exposure to benzene.

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Incidence of second cancers in patients treated for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Leukaemia in benzene workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Recent developments in benzene risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Leukemia following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Myeloid leukemia after cytotoxic therapy and other hematotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second malignancy after treatment of pediatric Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Children's susceptibility to chemicals: a review by developmental stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second malignant neoplasms in children: an update from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Myeloid neoplasia in children treated for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Leukemia in benzene workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Benzene and leukemia. An epidemiologic risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Cell intrinsic alterations underlie hematopoietic stem cell aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Cytogenetic and molecular analysis of therapy-related leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Overview of the toxicology of benzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Treatment of paediatric Hodgkin's disease. a balance of risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Bone marrow dysfunctions preceding acute leukemia in children: A clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second cancers following pediatric Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Recent findings and new initiatives for epidemiologic research on benzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15287390600975061

10.1080/15287390600975061

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17687725%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference